News

Johnson & Johnson agree Ollin Biosciences deal

BY Richard Summerfield

Johnson & Johnson has agreed to acquire biotech company Ollin Biosciences in a deal worth up to $3.33bn, which will expand its pipeline of eye disease therapies.

Under the terms of the deal, Johnson & Johnson will pay $2.2bn upfront, with the potential for additional regulatory and commercial milestone payments taking the total to $3.33bn.

The deal is expected to close by the end of 2026, subject to applicable regulatory approvals and other customary closing conditions.

The deal will give Johnson & Johnson access to Ollin’s lead drug, OLN324, which is set to be studied in late-stage trials as a treatment for wet age-related macular degeneration and diabetic macular oedema, both of which can lead to severe vision impairment.

Johnson & Johnson will also enter into a separate agreement with Blackstone Life Sciences for a $750m multi-year funding for the late-stage development of OLN324, in ⁠exchange for ​some payments and royalties.

“OLN324 selectively targets two important drivers of retinal disease and has the potential to achieve stronger and more sustained disease control,” said Kip Connor, vice president at Johnson & Johnson. “The data generated to date are compelling and point to a potentially transformative clinical profile that could deliver more effective reduction of retinal fluid and allow more time between treatments, ultimately redefining what is possible for patients.”

“Over the last three years, we’ve been on a mission to develop new therapies that improve the outcomes of patients with vision-threatening diseases,” said Jason S. Ehrlich, chief executive and co-founder of Ollin. “We’ve built a relentlessly execution-focused team and have rapidly advanced OLN324, generating compelling proof-of-concept data showing the potential for more effective improvements in retinal anatomy.

“We’re encouraged by what the future could hold and, subject to the completion of the transaction, the opportunity to build on our progress to date and further advance the development of OLN324 together,” he added.

“We founded Ollin with the conviction that pairing a world-class team with the capital necessary to acquire and smartly prosecute the development of next-generation therapeutics would allow us to challenge the status quo in ophthalmology,” said Paul Berns, managing director at ARCH Venture Partners, and co-founder and executive chairman of Ollin. “We’re confident that the potential acquisition of Ollin will enable OLN324 to reach as many patients as possible.”

Ollin, which has been backed by investment firms ARCH Venture ​Partners and Mubadala Capital, ​was established ⁠in 2023 to develop treatments for vision-threatening diseases. Its pipeline also includes OLN102, currently in preclinical development, for thyroid eye disease ​and Graves’ disease.

News: J&J to buy eye disease biotech Ollin Biosciences for up to $3.3 billion

Canaccord sells UK wealth arm for $1.3bn

BY Fraser Tennant

In a transaction valued at approximately $1.3bn, Canaccord Genuity Group’s UK wealth management business is to be acquired by private equity (PE) investors Mubadala Investment Company and Centerbridge Partners.

Under the terms of the definitive agreement, the two PE firms will create a joint entity and acquire the entire issued share capital of Canaccord Genuity Wealth Management (CGWM) in an all-cash transaction.

Canaccord Genuity’s UK capital markets business – Canaccord Genuity Limited – is not impacted by this transaction and remains integral to the company’s global capital markets platform.

“This transaction marks an important step in advancing our strategic priorities while supporting value creation for our shareholders,” said Dan Daviau, chairman and chief executive of Canaccord Genuity. “For CGWM UK, it provides continuity and a strong foundation for continued success for the benefit of clients and employees.”

Holding an approximate 66.9 percent equity equivalent interest in CGWM UK, Canaccord Genuity expects to receive proceeds of approximately £564m from the transaction after adjustments relating to debt and working capital, transaction costs and timing for closing.

Upon completion of the transaction – which has been approved by Canaccord Genuity’s board of directors – CGWM UK will be jointly owned by Centerbridge and Mubadala, with CGWM UK management and employees retaining a meaningful ownership interest.

“Under Canaccord Genuity Group’s stewardship, Canaccord Wealth has built a leading position in UK wealth management, combining strong growth with a reputation for exceptional client service,” said Yasir Badri, executive director of financial services at Mubadala. “Together with Centerbridge, we look forward to accelerating Canaccord Wealth’s momentum, strengthening its position as a trusted partner for clients and a preferred home for top-tier advisers.”

The transaction is expected to close in the first half of 2027, subject to customary closing conditions and the receipt of required regulatory approvals, including but not limited to the UK Financial Conduct Authority and the relevant financial services authorities in Jersey, Guernsey and the Isle of Man.

Ben Langworthy, senior managing director and head of Europe at Centerbridge, said: “We look forward to leveraging our track record on helping businesses grow through investment in talent, technology and supporting disciplined M&A, to help Canaccord Wealth on its next phase of growth.”

News: Mubadala, Centerbridge To Acquire Canaccord's UK Wealth Business In All-Cash Deal

Children’s Place files for Chapter 11 to effectuate sale

BY Fraser Tennant

In the wake of major losses and falling sales, New ‌Jersey-based clothing retailer Children’s Place has voluntarily filed petitions for Chapter 11 bankruptcy protection.

Reporting assets of $742.3m and liabilities of $881.3m as ​of 1 August 2026, the company and ‌13 of its affiliates sought protection from creditors in the Newark, New Jersey bankruptcy court. The company is also seeking recognition of the US Chapter 11 proceedings in Canada to include its Canadian assets and operations in the sale process.

In order to maximise value for all stakeholders, the company intends to file a motion requesting approval of a competitive marketing and sale process – designed to elicit the highest or otherwise best bid for the company’s assets with the goal of continuing the company’s business as a going concern and preserving the value of its brands.

The company is requesting parties to submit bids by 9 December 2026, and expects to complete the court-supervised sale process by the end of December 2026. Its stores and e-commerce sites remain open and continue to serve customers.

“This process marks an important step in our efforts to secure the best path forward for The Children’s Place,” said Rudy Morando, co-chief restructuring officer at Children’s Place. “For nearly 60 years, Children’s Place has supported growing families with apparel that customers have come to know and love.”

One of the only pure-play children’s specialty retailers in North America with an omni-channel presence, Children’s Place designs, contracts to manufacture and sells fashionable, high-quality, head to toe outfits predominantly at value prices, primarily under its proprietary brands: ‘The Children’s Place’ and ‘Gymboree’.

To fund its value-maximising restructuring process and go-forward operations, the company plans to enter into a new term loan facility provided by its existing secured lenders.

Subject to court approval, the company intends to continue its ongoing inventory sales across its store fleet designed to enhance liquidity and maintain operational flexibility, while providing families with access to deep discounts on fashionable, high-quality, head to toe outfits.

“We recognise the significance of this development for our employees, customers, vendors and other partners, and we are committed to conducting an efficient and transparent sale process,” added Mr Morando. “In the meantime, we remain focused on serving the families who have trusted Children’s Place for generations.”

News: Clothing retailer Children's Place files for bankruptcy, to seek sale

NRG sells power generation assets for $4bn

BY Richard Summerfield

NRG Energy Inc. has agreed to sell six natural gas generation assets to New York-based independent power company LS Power, for a purchase price of $4bn in cash, subject to working capital and other closing adjustments.

The sale is expected to close in the second quarter of 2027, subject to customary closing conditions and regulatory approvals.

The six assets represent 4.9 GW of generation across the New York Independent System Operator (Ravenswood), ISO-New England (Ocean State Power and Wallingford) and Electric Reliability Council of Texas (ERCOT) (Jack County, Johnson County and R.W. Miller).

Proceeds from the transaction will be used to support NRG’s 2027 pro forma capital allocation plan of $3bn of share repurchases across 2026 and 2027, including an incremental $1bn expected to begin before the end of the fourth quarter of 2026. Upon closing of the asset sale, NRG plans an additional $2bn of debt reduction to maintain the company’s current leverage profile, bringing total planned 2027 debt reduction to $3bn. The remaining proceeds will be reserved to fund either contracted growth investments or additional debt reduction.

Upon completion of the deal with LS Power, NRG will own and operate 20 GW of generation capacity, including 10 GW of generation in the ERCOT territory. The company said that by 2028, another 1.1 GW is expected to be operational in ERCOT through the company’s remaining two Texas Energy Fund projects.

“We are unlocking substantial value from a select group of assets, while maintaining a robust generation footprint in PJM and ERCOT that provides reliable, affordable power for our customers,” said Robert Gaudette, president and chief executive of NRG. “This transaction will strengthen our balance sheet, support increased share repurchases and preserve flexibility to invest in growth opportunities with compelling returns. It demonstrates our commitment to disciplined capital allocation and creates long-term value for shareholders.”

“Significant investment in firm, dispatchable power remains essential to grid reliability, and facilities that are already built, permitted, and interconnected deliver that power today,” said Paul Segal, chief executive of LS Power. “Firm power underpins our all-of-the-above approach, including renewables and distributed energy resources. Expanding LS Power's generation footprint in the Texas, Northeast, and New York markets, where we have deep experience developing and operating a range of energy infrastructure assets, creates opportunities to support historic levels of power demand growth.”

According to LS Power, the acquisition from NRG, combined with the company’s pending acquisition of about 4.4 GW in generation capacity from Constellation, will expand the group’s gas-fired generation fleet from 2.2 GW to 11.5 GW. LS Power also owns a variety of renewable energy assets, including solar, wind, hydro and battery energy storage, in a portfolio that will now exceed 19 GW of capacity.

The $4bn deal is not the first time the two companies have done business together. In 2025, NRG acquired LS Power’s natural gas generation facilities and a commercial and industrial virtual power plant platform portfolio in a cash and common stock deal valued at approximately $12bn.

News: NRG Energy to sell six power plants to LS Power for $4 billion

Mercer International files for Chapter 11 bankruptcy protection

BY Richard Summerfield

Canadian pulp manufacturer Mercer International Inc. has filed for Chapter 11 bankruptcy as part of a restructuring and recapitalisation deal that will slash its debt and bring in approximately $400m of new money.

The company, along with Mercer International (Texas) LLC, has entered a non-operating voluntary Chapter 11 prepackaged case in the US Bankruptcy Court for the Southern District of Texas. Completion of the recapitalisation is subject to customary conditions, including any requisite regulatory approvals, and the company is optimistic that it will be able to conclude this expedited Chapter 11 process by the end of 2026.

According to a statement announcing the recapitalisation deal, the agreement will see approximately $1.1bn of the company’s senior notes exchanged for equity, reducing existing senior note debt by approximately 88 percent, with minimal cash interest requirements over the first two years following emergence, and no bond maturities until 2031. The recapitalisation will eliminate approximately $96m of annual cash interest on the senior notes.

The company will also benefit from substantial new capital and liquidity, with $400m of new money being secured through a rights offering of new senior secured notes 100 percent backstopped by certain members of the ad hoc group of noteholders to provide significant liquidity to support Mercer’s operations post-emergence.

Going forward, existing shareholders will receive approximately 8.5 percent of the new common stock and 3.5 percent of the new convertible preferred stock of the reorganised company.

Mercer’s restructuring deal has support from holders of more than 87 percent of the outstanding principal amount of Mercer’s senior notes and a majority of the outstanding shares of its common stock.

According to Mercer, the company and its operating businesses will continue to operate in the ordinary course of business during the restructuring process. Its customers will continue to be served, vendors and unsecured claims will be paid in the ordinary course, and employee wages and benefits will continue without interruption

“This transaction is a decisive step forward for Mercer and is the result of constructive and arm’s-length negotiations between Mercer and key stakeholder groups,” said Juan Carlos Bueno, president and chief executive of Mercer. “With the support of the majority of our noteholders and shareholders, we are putting in place a much stronger balance sheet and the liquidity to navigate current pulp and lumber market and geopolitical conditions. Upon emergence, we will be better positioned to invest in, and grow, our business.

“This is a balance sheet recapitalization only. Our mills in Germany, Canada and the United States are operating as usual, and we expect to continue to meet our commitments to customers, suppliers and employees in the ordinary course,” he added.

Mr Bueno also thanked the company’s employees for their dedication and hard work, as well as its customers, suppliers, community partners, noteholders and shareholders for their continued support and confidence in Mercer’s future. He said this backing demonstrated faith in the company’s people, long-term strategy and portfolio of pulp, lumber and mass timber products, and expressed confidence that Mercer would complete the process efficiently and emerge as a stronger business.

News: Mercer International to file prepackaged Chapter 11, swap $1.1 billion of notes for equity

©2001-2026 Financier Worldwide Ltd. All rights reserved. Any statements expressed on this website are understood to be general opinions and should not be relied upon as legal, financial or any other form of professional advice. Opinions expressed do not necessarily represent the views of the authors’ current or previous employers, or clients. The publisher, authors and authors' firms are not responsible for any loss third parties may suffer in connection with information or materials presented on this website, or use of any such information or materials by any third parties.